SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNationwide Ccds Regulatory News (NBS)

Share Price Information for Nationwide Ccds (NBS)

Share Price is delayed by 15 minutes
Get Live Data
129.00    0.00 (0.00%)
Bid:
127.00
Ask:
131.00
Spread: 4.00 (3.15%)
Market Cap: £1.18b
NBS Live PriceLast checked at - London Stock Exchange

Intraday Nationwide Ccds Share Chart

DTR 5 Announcement

14 Sep 2017 13:45

RNS Number : 7875Q
Nationwide Building Society
14 September 2017
 

14 September 2017

Nationwide Building Society

(the "Society")

Core Capital Deferred Shares

(GB00BBQ33664)

(the "CCDS")

NOTICE IS HEREBY GIVEN by the Society, pursuant to DTR5.8.12R, that the Society received on 14 September 2017 a TR-1 form in respect of the CCDS from Citivic Nominees Limited (the "Nominee"). 

The TR-1 form confirmed that the Nominee is the registered holder of all of the 10,500,000 CCDS issued by the Society, comprising the 5,500,000 CCDS issued on 6 December 2013 and the 5,000,000 further CCDS issued on 14 September 2017.

Interests in the CCDS are held by beneficial owners through accounts with Euroclear Bank SA/NV and Clearstream Banking, S.A. and, whilst so held, the legal title to all of the CCDS is registered in the name of the Nominee as nominee for those clearing systems. The members' rights attaching to the CCDS so held will be held by the Nominee, who will be entitled to exercise (without following instructions given in writing or by electronic means) the voting and other members' rights attributable to all those CCDS so held.

The Nominee, in its capacity as a member of the Society, shall have only one vote (regardless of the number of CCDS held by it and regardless also of the size and number of other relevant investments or interests (if any) conferring membership rights which the Nominee may have in the Society) on any resolution put to members of the Society generally.

Given the difficulty of casting the single vote attaching to the CCDS at a general meeting of the members of the Society in a manner which reflects the views of all the investors holding CCDS through a clearing system and the relative insignificance of that vote in the context of all the votes which may be cast by members of the Society, the Nominee has informed the Society that it does not intend to exercise its vote insofar as such vote relates to its holding of CCDS.

For further information, please contact

Nationwide Building Society

One Threadneedle Street

London EC2R 8AW

Alex Wall

Head of Capital, Ratings & Investor Relations

Telephone: +44 (0) 20 7261 6568

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLSFFFELFWSELU
Date   Source Headline
12th Jun 20262:02 pmRNSPublication of a Prospectus
12th Jun 202611:31 amRNSPublication of Registration Document
12th Jun 202611:24 amRNSPublication of a Prospectus
9th Jun 202611:15 amRNSAdmission to Trading
8th Jun 202611:52 amRNSNOTICE TO NOTEHOLDERS
5th Jun 20262:58 pmRNSPublication of Final Terms
21st May 202612:33 pmRNSPublication of a Supplementary Prospectus
21st May 20267:00 amRNSPreliminary Results Announcement
6th May 20263:12 pmRNSPublication of Final Terms
21st Apr 20263:38 pmRNSPublication of Final Terms
21st Apr 202610:20 amRNSCancellation of Listing
20th Apr 202612:38 pmRNSNotice to Covered Bondholders
9th Apr 202611:06 amRNSPublication of a Supplementary Prospectus
7th Apr 20267:00 amRNSPart VII Transfer & Board changes
20th Mar 20268:48 amRNSRedemption of Securities
3rd Mar 202611:50 amRNSAdmission to Trading
3rd Mar 202611:44 amRNSAdmission to Trading
27th Feb 20265:18 pmRNSPublication of Final Terms
27th Feb 20263:56 pmRNSPublication of Final Terms
26th Feb 202611:00 amRNSPart VII Transfer
24th Feb 20269:51 amRNSAdmission to Trading
20th Feb 20269:47 amRNSPublication of Final Terms
19th Feb 202610:04 amRNSAdmission to Trading
17th Feb 20269:56 amRNSAdmission to Trading
17th Feb 20269:46 amRNSPublication of Final Terms
13th Feb 20262:04 pmRNSPublication of Final Terms
13th Feb 20268:15 amRNSPost Stabilisation Notice
3rd Feb 20262:41 pmRNSAdmission to Trading
30th Jan 20261:00 pmRNSPublication of Final Terms
16th Jan 20261:21 pmRNSPublication of Final Terms
8th Jan 20261:49 pmRNSPublication of Final Terms
8th Jan 20267:00 amRNSDirectorate change
7th Jan 202610:49 amRNSPre Stabilisation Notice
19th Dec 202511:00 amRNSDirectorate change
19th Dec 202511:00 amRNSDirectorate change
16th Dec 20252:42 pmRNSPublication of a Supplementary Prospectus
2nd Dec 20257:10 amRNSResponse to 2025 BOE Capital Stress Test Results
2nd Dec 20257:00 amRNSRevocation of Sub-consolidation Direction
20th Nov 202511:47 amRNSPublication of Supplement
20th Nov 20257:00 amRNSInterim Results September 2025
14th Nov 202511:00 amRNSPart VII Transfer
21st Oct 20251:08 pmRNSPublication of Final Terms
10th Oct 202512:52 pmRNSPublication of Final Terms
1st Oct 20257:00 amRNSConfirmation of Post-Offer Intention Statements
30th Sep 202510:03 amRNSBoard Changes
30th Sep 20259:43 amRNSBoard Changes
30th Sep 20257:00 amRNSBoard Changes
26th Sep 20252:49 pmRNSPublication of Final Terms
16th Sep 20251:48 pmRNSPublication of Final Terms
8th Sep 202511:27 amRNSPublication of Final Terms

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.